| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 98.3558 | 75 |
| GSM780708 | Untreated after 4 days (C2_1) | 95.9787 | 75 |
| GSM780709 | Untreated after 4 days (C3_1) | 87.3143 | 73 |
| GSM780719 | Untreated after 4 days (C1_2) | 98.965 | 75 |
| GSM780720 | Untreated after 4 days (C2_2) | 92.8993 | 74 |
| GSM780721 | Untreated after 4 days (C3_2) | 80.9522 | 72 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 87.6284 | 73 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 95.1015 | 74 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 90.4932 | 74 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 79.0891 | 71 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 95.4197 | 75 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 82.0855 | 72 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 93.3237 | 74 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 87.6953 | 73 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 87.4531 | 73 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 107.349 | 76 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 82.8471 | 72 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 85.5144 | 73 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 84.2656 | 73 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 80.869 | 72 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 90.6022 | 74 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 75.4176 | 71 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 82.5091 | 72 |